LaRussa Michele 4
4 · Kala Pharmaceuticals, Inc. · Filed Feb 9, 2018
Insider Transaction Report
Form 4
LaRussa Michele
Sr. VP, Regulatory and Quality
Transactions
- Award
Stock Option (right to buy)
2018-02-07+8,000→ 8,000 totalExercise: $12.86Exp: 2028-02-06→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 7, 2018 and vests with respect to 1/48th of the shares underlying the option at the end of each successive one-month period thereafter.